TP53 and myelodysplastic syndrome: Although ASXL1 and DNMT3A mutations were frequent in AA, MDS and AML, there is a substantial underrepresentation of mutations in splicing-factor genes, JAK2, and TP53 in AA compared with MDS and AML, reflecting the difference in the mechanism of clonal selection between both diseases and mutations.